Specialty Pharma Report: Antiageing and Life Enhancement Drug Markets Poised for Exceptional Growth to 2012 According to New Research Study by Spectra Intelligence

Share Article

In a market currently valued at US $36 billion, pharmacotherapies for conditions such as sleep disorders, addictions, depression, infertility, sexual disorders, and chronological ageing, are forecast to triple in value to over US $100 billion by 2020.

Spectra`s new data-intensive study, Antiaging and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets to 2012 and Beyond, predicts dramatic expansion based on increasing aging populations, high unmet needs related to aging and lifestyle dissatisfaction, unrelenting media fixation on youthfulness and image, and pharmacological innovation. With more than 90 marketed products evaluated and over 270 candidates identified in clinical development, this unique 580-page comprehensive multi part report, covering over 15 major therapy areas, provides unrivaled analysis of the enlarging dynamic market, and illustrates high-growth market sectors and prospects that may be positioned for market dominance on commercialization.

Combining extensive research methodology with analytical and strategic review, the study offers a unique insight to the scope of the product market and development pipeline and shows, for example, how ethical drugs are increasingly being used in a therapeutic switch capacity to target cosmetic antiaging and life enhancement. Furthermore, drugs in development in the field are shown to be highly sophisticated products with multiple therapeutic benefits which may revolutionize medical treatments across a number of therapy areas.

Further report details and ordering information can be obtained by contacting Roger Myhill at reports@spectraintelligence.com or by visiting our website at http://www.spectraintelligence.com

About Spectra Intelligence

Spectra Intelligence specializes in publishing independent market research information for the global life sciences. The company conducts in-depth research studies in core therapeutic areas, markets, technologies, and management issues to offer comprehensive competitive intelligence solutions and strategic insight. In addition to high-quality syndicated market research reports, Spectra also combines research methodology with proprietary forecasting tools to offer focused strategic planning and consultancy services.

Contact: Roger Myhill at Spectra Intelligence, +44 (0)20 8671 7726 or



# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Roger Myhill
Visit website